Congress trades
DENTSPLY SIRONA Inc. (XRAY)
About DENTSPLY SIRONA Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Chief executive
- Daniel T. Scavilla
- Employees
- 14,000
- Listed since
- Aug 12, 1987
- Market value
- $2.1B
- Price to earnings
- -
- Earnings per share
- -$2.73
- Dividend yield
- 2.99%
Earnings
6 reported quarters · next on Nov 5, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 6, 2026 | $0.52 | $0.35 | $898.0M | $889.9M | EPS beatRevenue in line |
| Q1 FY2026reported May 5, 2026 | $0.27 | $0.28 | $880.0M | $841.8M | EPS missRevenue beat |
| Q4 FY2025reported Feb 26, 2026 | $0.27 | $0.28 | $961.0M | $926.2M | EPS missRevenue beat |
| Q3 FY2025reported Nov 6, 2025 | $0.37 | $0.45 | $904.0M | $927.1M | EPS missRevenue miss |
| Q2 FY2025reported Aug 7, 2025 | $0.52 | $0.50 | $936.0M | $904.6M | EPS beatRevenue beat |
| Q1 FY2025reported May 8, 2025 | $0.43 | $0.29 | $879.0M | $920.2M | EPS beatRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Apr 23, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Daniel T. ScavillaPresident and Chief Executive Officer | $432K | $3.5M | $4.8M | $8.8M |
| Robert (Tony) A. JohnsonSenior Vice President, Chief Supply Chain Officer | $572K | $1.4M | $3.7M | $5.7M |
| Andrea L. FrohningSenior Vice President, Chief Human Resources Officer | $481K | $810K | $1.1M | $2.4M |
| Aldo M. DentiExecutive Vice President, Chief Commercial Officer | $188K | $0 | $1.3M | $1.5M |
The summary compensation table from the 2025 proxy statement, current executives only. 3 executives who have since left the company are named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $283.4M | 26,711,079 | +38.7% | 13.38% |
| Fuller & Thaler Asset Management, Inc. | $134.7M | 12,697,269 | -0.7% | 6.36% |
| Vanguard Portfolio Management LLC | $125.0M | 11,779,851 | +11.9% | 5.90% |
| AQR Capital Management LLC | $110.2M | 10,458,771 | +163.8% | 5.24% |
| State Street Corp | $98.5M | 9,285,298 | +28.2% | 4.65% |
| Vanguard Capital Management LLC | $96.0M | 9,047,628 | +0.5% | 4.53% |
| Lazard Asset Management LLC | $87.7M | 8,269,867 | +23.1% | 4.14% |
| Ariel Investments, LLC | $85.2M | 8,026,107 | +25.7% | 4.02% |
| Southpoint Capital Advisors LP | $74.3M | 7,000,000 | -30.0% | 3.51% |
| Cooke & Bieler LP | $73.5M | 6,927,915 | -11.2% | 3.47% |
| Geode Capital Management, LLC | $60.0M | 5,650,605 | +47.8% | 2.83% |
| Invenomic Capital Management LP | $52.1M | 4,909,808 | +11.8% | 2.46% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in XRAY
20 disclosures of 36 on record · median 36d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | -42.4%S&P +29.5% · vs S&P 500 -71.8% | Jan 7, 2025 | Feb 11, 2025 | 35d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | -43.1%S&P +29.3% · vs S&P 500 -72.4% | Jan 8, 2025 | Feb 11, 2025 | 34d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -63.3%S&P +75.5% · vs S&P 500 -138.8% | Nov 3, 2023 | Dec 6, 2023 | 33d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -68.3%S&P +78.5% · vs S&P 500 -146.7% | Oct 2, 2023 | Nov 8, 2023 | 37d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -72.3%S&P +84.8% · vs S&P 500 -157.0% | May 2, 2022 | Jun 10, 2022 | 39d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -74.5%S&P +71.6% · vs S&P 500 -146.2% | Apr 19, 2022 | May 25, 2022 | 36d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -77.3%S&P +74.1% · vs S&P 500 -151.4% | Apr 11, 2022 | May 6, 2022 | 25d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | -80.0%S&P +67.0% · vs S&P 500 -146.9% | Feb 2, 2022 | Mar 17, 2022 | 43d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | -81.0%S&P +71.2% · vs S&P 500 -152.2% | Feb 15, 2022 | Mar 17, 2022 | 30d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | -81.0%S&P +71.0% · vs S&P 500 -152.0% | Feb 16, 2022 | Mar 17, 2022 | 29d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -79.9%S&P +72.8% · vs S&P 500 -152.7% | Jan 28, 2022 | Feb 23, 2022 | 26d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | -79.2%S&P +66.2% · vs S&P 500 -145.3% | Dec 5, 2021 | Jan 16, 2022 | 42d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | -78.9%S&P +68.1% · vs S&P 500 -147.0% | Dec 3, 2021 | Jan 16, 2022 | 44d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -80.3%S&P +63.5% · vs S&P 500 -143.8% | Nov 5, 2021 | Dec 7, 2021 | 32d |
| Michael T. McCaulFiled late | Stock | Sale | $1,001 - $15,000 | -83.2%S&P +77.4% · vs S&P 500 -160.6% | Jul 1, 2021 | Aug 18, 2021 | 48d |
| Michael T. McCaulFiled late | Stock | Sale | $15,001 - $50,000 | -83.2%S&P +77.4% · vs S&P 500 -160.6% | Jul 1, 2021 | Aug 18, 2021 | 48d |
| Michael T. McCaulFiled late | Stock | Purchase | $1,001 - $15,000 | -80.1%S&P +108.3% · vs S&P 500 -188.4% | Dec 10, 2020 | Jan 25, 2021 | 46d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -74.8%S&P +135.8% · vs S&P 500 -210.7% | Sep 23, 2020 | Oct 21, 2020 | 28d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | -71.5%S&P +166.9% · vs S&P 500 -238.4% | May 15, 2020 | Jun 15, 2020 | 31d |
| Michael T. McCaulFiled late | Stock | Purchase | $15,001 - $50,000 | -71.3%S&P +203.3% · vs S&P 500 -274.6% | Apr 2, 2020 | May 18, 2020 | 46d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded XRAY?
Gilbert Ray Cisneros, Jr., Ro Khanna, Michael T. McCaul, Lois Frankel disclosed XRAY transactions in the filings shown here.
How quickly are XRAY trades disclosed?
Congressional disclosures took a median of 36 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.